These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 22596054)
1. Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy. Guo T; Bond ND; Jou W; Gavrilova O; Portas J; McPherron AC Diabetes; 2012 Oct; 61(10):2414-23. PubMed ID: 22596054 [TBL] [Abstract][Full Text] [Related]
2. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. Guo T; Jou W; Chanturiya T; Portas J; Gavrilova O; McPherron AC PLoS One; 2009; 4(3):e4937. PubMed ID: 19295913 [TBL] [Abstract][Full Text] [Related]
3. Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity. McPherron AC; Guo T; Wang Q; Portas J Diabetes Obes Metab; 2012 Mar; 14(3):279-82. PubMed ID: 22023380 [TBL] [Abstract][Full Text] [Related]
4. Loss-of-function myostatin mutation increases insulin sensitivity and browning of white fat in Meishan pigs. Cai C; Qian L; Jiang S; Sun Y; Wang Q; Ma D; Xiao G; Li B; Xie S; Gao T; Chen Y; Liu J; An X; Cui W; Li K Oncotarget; 2017 May; 8(21):34911-34922. PubMed ID: 28432282 [TBL] [Abstract][Full Text] [Related]
5. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Wilkes JJ; Lloyd DJ; Gekakis N Diabetes; 2009 May; 58(5):1133-43. PubMed ID: 19208906 [TBL] [Abstract][Full Text] [Related]
6. A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice. Wang Q; Guo T; Portas J; McPherron AC Int J Biol Sci; 2015; 11(2):199-208. PubMed ID: 25561902 [TBL] [Abstract][Full Text] [Related]
7. Increasing muscle mass to improve metabolism. McPherron AC; Guo T; Bond ND; Gavrilova O Adipocyte; 2013 Apr; 2(2):92-8. PubMed ID: 23805405 [TBL] [Abstract][Full Text] [Related]
8. Myostatin propeptide mutation of the hypermuscular Kocsis T; Trencsenyi G; Szabo K; Baan JA; Muller G; Mendler L; Garai I; Reinauer H; Deak F; Dux L; Keller-Pinter A Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E150-E160. PubMed ID: 27965203 [TBL] [Abstract][Full Text] [Related]
9. Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake. Bonala S; Lokireddy S; McFarlane C; Patnam S; Sharma M; Kambadur R J Biol Chem; 2014 Mar; 289(11):7654-70. PubMed ID: 24451368 [TBL] [Abstract][Full Text] [Related]
10. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Zhang C; McFarlane C; Lokireddy S; Bonala S; Ge X; Masuda S; Gluckman PD; Sharma M; Kambadur R Diabetologia; 2011 Jun; 54(6):1491-501. PubMed ID: 21347623 [TBL] [Abstract][Full Text] [Related]
11. IGF1 stimulates greater muscle hypertrophy in the absence of myostatin in male mice. Hennebry A; Oldham J; Shavlakadze T; Grounds MD; Sheard P; Fiorotto ML; Falconer S; Smith HK; Berry C; Jeanplong F; Bracegirdle J; Matthews K; Nicholas G; Senna-Salerno M; Watson T; McMahon CD J Endocrinol; 2017 Aug; 234(2):187-200. PubMed ID: 28533420 [TBL] [Abstract][Full Text] [Related]
12. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity. Straub LG; Efthymiou V; Grandl G; Balaz M; Challa TD; Truscello L; Horvath C; Moser C; Rachamin Y; Arnold M; Sun W; Modica S; Wolfrum C Diabetologia; 2019 Nov; 62(11):2094-2105. PubMed ID: 31309261 [TBL] [Abstract][Full Text] [Related]
13. Enhanced skeletal muscle growth in myostatin-deficient transgenic pigs had improved glucose uptake in stretozotocin-induced diabetes. Li B; Cui W; Yang J Transgenic Res; 2020 Apr; 29(2):253-261. PubMed ID: 32078127 [TBL] [Abstract][Full Text] [Related]
14. Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults. Carvalho LP; Basso-Vanelli RP; Di Thommazo-Luporini L; Mendes RG; Oliveira-Junior MC; Vieira RP; Bonjorno-Junior JC; Oliveira CR; Luporini R; Borghi-Silva A Cytokine; 2018 Jul; 107():118-124. PubMed ID: 29246653 [TBL] [Abstract][Full Text] [Related]
15. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W Diabetes; 2009 Aug; 58(8):1739-48. PubMed ID: 19509018 [TBL] [Abstract][Full Text] [Related]
16. Analysis of paradoxical observations on the association between leptin and insulin resistance. Ceddia RB; Koistinen HA; Zierath JR; Sweeney G FASEB J; 2002 Aug; 16(10):1163-76. PubMed ID: 12153984 [TBL] [Abstract][Full Text] [Related]
17. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608 [TBL] [Abstract][Full Text] [Related]
18. An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice. Rong X; Li Y; Ebihara K; Zhao M; Aini W; Kusakabe T; Hirata M; Miyamoto L; Murray M; Nakao K J Pharmacol Exp Ther; 2009 Dec; 331(3):1096-103. PubMed ID: 19770292 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Zhang C; McFarlane C; Lokireddy S; Masuda S; Ge X; Gluckman PD; Sharma M; Kambadur R Diabetologia; 2012 Jan; 55(1):183-93. PubMed ID: 21927895 [TBL] [Abstract][Full Text] [Related]
20. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice. Allen DL; Cleary AS; Lindsay SF; Loh AS; Reed JM J Appl Physiol (1985); 2010 Sep; 109(3):692-701. PubMed ID: 20595541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]